These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 935128)

  • 21. Body mass index and cardiovascular risk factors and biomarkers in hemodialysis patients.
    Bossola M; Giungi S; Panocchia N; Vulpio C; Luciani G; Tazza L
    J Nephrol; 2008; 21(2):197-204. PubMed ID: 18446714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients.
    Yang WS; Kim SB; Min WK; Park S; Lee MS; Park JS
    Nephrol Dial Transplant; 1995; 10(9):1668-71. PubMed ID: 8559487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
    Kimak E; Ksiazek A; Baranowicz-Gaszczyk I; Solski J
    Ren Fail; 2007; 29(6):705-12. PubMed ID: 17763166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Women and men with hypercholesterolemia respond similarly to an American Heart Association step 1 diet.
    Geil PB; Anderson JW; Gustafson NJ
    J Am Diet Assoc; 1995 Apr; 95(4):436-41. PubMed ID: 7699185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are erythropoietin levels in uraemic patients on haemodialysis dependent on the kidney disease and the duration of haemodialysis treatment?
    Walle AJ; Niedermayer W
    Proc Eur Dial Transplant Assoc; 1979; 16():481-6. PubMed ID: 548991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
    Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
    Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of long-term treatment with L-carnitine on dyslipemia in hemodialysis patients].
    Dionisio P; Bergia R; Caramello E; Graziola M; Valenti M; Bajardi P; Barbera L; Voglino F
    Minerva Med; 1985 Feb; 76(6):229-34. PubMed ID: 3974937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Charcoal-induced lipid reduction in uremia.
    Friedman EA; Feinstein EI; Beyer MM; Galonsky RS; Hirsch SR
    Kidney Int Suppl; 1978 Jun; (8):S170-6. PubMed ID: 278886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid metabolism in uremia: effect of regular hemofiltration and hemodialysis treatment.
    Henning HV; Balusek E
    J Dial; 1977; 1(6):595-605. PubMed ID: 608870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carnitine improves lipid anomalies in haemodialysis patients.
    Lacour B; Di Giulio S; Chanard J; Ciancioni C; Haguet M; Lebkiri B; Basile C; Drüeke T; Assan R; Funck-Brentano JL
    Lancet; 1980 Oct; 2(8198):763-4. PubMed ID: 6107451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term effect of magnesium on lipid metabolism in uraemic rats.
    Inagaki O; Fujita Y
    Magnes Res; 1991; 4(3-4):191-5. PubMed ID: 1799554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes and correlations of antioxidant enzymes, lipid peroxidation and serum neutral lipids due to haemodialysis treatment in chronic uraemic patients.
    Matkovics B; László A; Varga SI; Gál G; Solymosi T
    Int Urol Nephrol; 1988; 20(5):559-64. PubMed ID: 3235307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid metabolism in non-uremic and uremic dogs during and after hemodialysis with acetate.
    Morin RJ; Guo LS; Rorke SJ; Davidson WD
    J Dial; 1978; 2(2):113-29. PubMed ID: 681578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum magnesium and nerve conduction velocity in uraemic patients on chronic haemodialysis.
    Cisari C; Gasco P; Calabrese G; Pratesi G; Gonella M
    Magnes Res; 1989 Dec; 2(4):267-9. PubMed ID: 2642071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serum lipids in stroke].
    Koziak M
    Neurol Neurochir Pol; 1978; 12(2):121-8. PubMed ID: 673118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased concentrations of serum phospholipid plasmalogens indicate oxidative burden of uraemic patients undergoing haemodialysis.
    Brosche T; Platt D; Knopf B
    Nephron; 2002 Jan; 90(1):58-63. PubMed ID: 11744806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma lipids and fatty acid levels in chronically uremic patients undergoing blood purification with different methods.
    Marangoni R; Civardi F; Savino R; Colombo R; Marangoni F; Mosconi C; Galli C
    Artif Organs; 1992 Dec; 16(6):625-9. PubMed ID: 1482334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serum gastrin in uraemic patients on intermittent haemodialysis following a test meal (author's transl)].
    Pointner H; Flegel U; Schmidt P; Zazgornik J; Kopsa H; Waldhäusl W
    Wien Klin Wochenschr; 1974 Nov; 86(22):699-702. PubMed ID: 4460394
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.